|
Powered by Cell Signaling Technology |
Site Information |
---|
QstsRHkkLMFktEG SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 458977 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on p53: | |
Effects of modification on biological processes: | |
Induce interaction with: | |
Inhibit interaction with: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Kanellis DC, et al. (2023) Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death Differ
37142656 Curated Info |
|
Ko HJ, et al. (2022) BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death. Cell Commun Signal 20, 200
36575468 Curated Info |
|
Kim U, Kim KS, Park JK, Um HD (2022) Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complex. Biochem Biophys Res Commun 635, 52-56
36257192 Curated Info |
|
Malhotra L, et al. (2022) Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer. Biochim Biophys Acta Mol Cell Res 1869, 119343
36007676 Curated Info |
|
Phorl S, et al. (2022) Opposing roles of HDAC6 in liver regeneration and hepatocarcinogenesis. Cancer Sci 113, 2311-2322
35534985 Curated Info |
|
Yoon JY, et al. (2022) Metabolic rescue ameliorates mitochondrial encephalo-cardiomyopathy in murine and human iPSC models of Leigh syndrome. Clin Transl Med 12, e954
35872650 Curated Info |
|
Chen H, et al. (2022) SIRT1-mediated p53 deacetylation inhibits ferroptosis and alleviates heat stress-induced lung epithelial cells injury. Int J Hyperthermia 39, 977-986
35853732 Curated Info |
|
Cai MY, et al. (2022) Role of Carbon Monoxide in Oxidative Stress-Induced Senescence in Human Bronchial Epithelium. Oxid Med Cell Longev 2022, 5199572
36193088 Curated Info |
|
Alhebshi H, et al. (2021) Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer. Int J Mol Sci 22
34947995 Curated Info |
|
Zhou Q, et al. (2021) Up-regulation of PUMA caused the activation of p53 phosphorylation and acetylation, enhancing the interaction between PUMA and Bcl-X and mediating arsenic-induced apoptosis. Toxicol Appl Pharmacol 434, 115800
34798143 Curated Info |
|
Storchova R, et al. (2021) A novel assay for screening WIP1 phosphatase substrates in nuclear extracts. FEBS J 288, 6035-6051
33982878 Curated Info |
|
Yao JY, et al. (2021) Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling. Acta Pharmacol Sin
34188177 Curated Info |
|
Wang J, et al. (2021) Olmesartan Prevents Oligomerized Amyloid β (Aβ)-Induced Cellular Senescence in Neuronal Cells. ACS Chem Neurosci 12, 1162-1169
33710861 Curated Info |
|
King VL, Leclair NK, Coulter AM, Campellone KG (2021) The actin nucleation factors JMY and WHAMM enable a rapid Arp2/3 complex-mediated intrinsic pathway of apoptosis. PLoS Genet 17, e1009512
33872315 Curated Info |
|
Stocks B, et al. (2021) Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise. J Physiol 599, 1513-1531
33492681 Curated Info |
|
Chen T, et al. (2021) SIRT3 protects endothelial cells from high glucose-induced senescence and dysfunction via the p53 pathway. Life Sci 264, 118724
33160987 Curated Info |
|
Veena MS, et al. (2020) Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer. J Biol Chem 295, 17169-17186
33028635 Curated Info |
|
Xu X, et al. (2020) Autophagic feedback-mediated degradation of IKKα requires CHK1- and p300/CBP-dependent acetylation of p53. J Cell Sci 133
33097607 Curated Info |
|
Lees A, et al. (2020) The pseudo-caspase FLIP(L) regulates cell fate following p53 activation. Proc Natl Acad Sci U S A 117, 17808-17819
32661168 Curated Info |
|
Di Meo F, et al. (2020) Prevents Oxidative Stress-Induced Apoptosis Blocking p53 Activation in Neuroblastoma Cells. Antioxidants (Basel) 9
32224984 Curated Info |
|
Jiang X, Wang J (2020) Knockdown of TFAM in Tumor Cells Retarded Autophagic Flux through Regulating p53 Acetylation and PISD Expression. Cancers (Basel) 12
32093281 Curated Info |
|
Wang Y, et al. (2020) The role of acetylation sites in the regulation of p53 activity. Mol Biol Rep 47, 381-391
31680191 Curated Info |
|
Khan MA, et al. (2020) Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients. PLoS One 15, e0238500
32976537 Curated Info |
|
Li XH, et al. (2020) p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2. Cancer Cell Int 20, 398
32831651 Curated Info |
|
Cai W, et al. (2019) PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth. Nat Commun 10, 5800
31863007 Curated Info |
|
Tanaka T, et al. (2019) Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fate. Biochim Biophys Acta Mol Cell Res 1866, 118560
31634504 Curated Info |
|
Shao J, et al. (2019) Derepression of LOXL4 inhibits liver cancer growth by reactivating compromised p53. Cell Death Differ 26, 2237-2252
30728460 Curated Info |
|
Choi SH, et al. (2019) Temporal and differential regulation of KAISO-controlled transcription by phosphorylated and acetylated p53 highlights a crucial regulatory role of apoptosis. J Biol Chem 294, 12957-12974
31296660 Curated Info |
|
Bi J, et al. (2019) Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life 71, 978-985
31026379 Curated Info |
|
Lee BB, et al. (2019) Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells. J Cell Mol Med 23, 2872-2889
30710424 Curated Info |
|
Di Leo L, et al. (2019) Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53. Oncogene 38, 1860-1875
30367149 Curated Info |
|
Potenza MA, et al. (2019) Activation of AMPK/SIRT1 axis is required for adiponectin-mediated preconditioning on myocardial ischemia-reperfusion (I/R) injury in rats. PLoS One 14, e0210654
30653603 Curated Info |
|
Sun MY, et al. (2019) Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway. Cancer Manag Res 11, 1069-1080
30774435 Curated Info |
|
Zhang Y, et al. (2019) HOXA10 knockdown inhibits proliferation, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells through HDAC1. Cancer Manag Res 11, 7065-7076
31440094 Curated Info |
|
Chen SL, et al. (2018) A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma. Cancer Res
30584071 Curated Info |
|
Ali R, et al. (2018) Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention. Cancer Res
30297533 Curated Info |
|
Luff SA, Kao CY, Papoutsakis ET (2018) Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis. PLoS One
30231080 Curated Info |
|
Castrogiovanni C, Waterschoot B, De Backer O, Dumont P (2018) Serine 392 phosphorylation modulates p53 mitochondrial translocation and transcription-independent apoptosis. Cell Death Differ 25, 190-203
28937686 Curated Info |
|
Zheng S, et al. (2017) Inhibiting p53 Acetylation Reduces Cancer Chemotoxicity. Cancer Res 77, 4342-4354
28655792 Curated Info |
|
Liu L, et al. (2017) Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma. Oncotarget 8, 43990-44003
28410205 Curated Info |
|
Calapre L, et al. (2017) SIRT1 activation mediates heat-induced survival of UVB damaged Keratinocytes. BMC Dermatol 17, 8
28601088 Curated Info |
|
Xu L, et al. (2017) BCL6 promotes glioma and serves as a therapeutic target. Proc Natl Acad Sci U S A 114, 3981-3986
28356518 Curated Info |
|
Ryu HW, et al. (2017) HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis. Cancer Lett 391, 162-171
28153791 Curated Info |
|
Yuan H, et al. (2017) Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy. Oncotarget 8, 14912-14924
28118604 Curated Info |
|
Wang G, et al. (2017) Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway. Cell Death Dis 8, e2607
28182012 Curated Info |
|
Ferrer CM, et al. (2017) O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway. Oncogene 36, 559-569
27345396 Curated Info |
|
Bao L, et al. (2016) Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation. Cell Biol Toxicol 32, 469-482
27423454 Curated Info |
|
Choi OR, Ryu MS, Lim IK (2016) Shifting p53-induced senescence to cell death by TIS21(/BTG2/Pc3) gene through posttranslational modification of p53 protein. Cell Signal 28, 1172-85
27208501 Curated Info |
|
de Queiroz RM, et al. (2016) Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells. J Biol Chem 291, 18897-914
27402830 Curated Info |
|
Knyphausen P, et al. (2016) Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins. J Biol Chem 291, 14677-94
27226597 Curated Info |
|
Sriraman A, et al. (2016) Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity. Oncotarget 7, 31623-38
27183917 Curated Info |
|
Conrad E, et al. (2016) HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism. Cell Death Differ 23, 110-22
26113041 Curated Info |
|
Zheng YC, et al. (2016) 1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors. Cell Physiol Biochem 38, 185-93
26784898 Curated Info |
|
Park JB (2016) Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor. PLoS One 11, e0150392
26986569 Curated Info |
|
Phang BH, et al. (2015) Amino-terminal p53 mutations lead to expression of apoptosis proficient p47 and prognosticate better survival, but predispose to tumorigenesis. Proc Natl Acad Sci U S A 112, E6349-58
26578795 Curated Info |
|
Agarwal S, Bell CM, Rothbart SB, Moran RG (2015) AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells. J Biol Chem 290, 27473-86
26391395 Curated Info |
|
Qi J, et al. (2015) HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation. Cell Stem Cell 17, 597-610
26387755 Curated Info |
|
Lee WY, et al. (2015) Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1. Oncotarget 6, 27580-95
26363315 Curated Info |
|
Seo SK, et al. (2015) Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation. Oncotarget 6, 26528-40
25605253 Curated Info |
|
Zhao B, et al. (2015) Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways. Oncotarget 6, 10116-33
25426556 Curated Info |
|
Donninger H, et al. (2015) NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2. J Cell Biol 208, 777-89
25778922 Curated Info |
|
Choi HK, et al. (2015) Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response. Nat Commun 6, 7390
26077467 Curated Info |
|
Kovalev RA, et al. (2015) [Histone deacetylase inhibitors cause the TP53-dependent induction of p21/Waf1 in tumor cells carrying mutations in TP53]. Tsitologiia 57, 204-11
26021170 Curated Info |
|
Zhang E, et al. (2015) Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway. PLoS One 10, e0143814
26629991 Curated Info |
|
Sutendra G, et al. (2014) A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation. Cell 158, 84-97
24995980 Curated Info |
|
Liu L, et al. (2014) Exogenous NAD(+) supplementation protects H9c2 cardiac myoblasts against hypoxia/reoxygenation injury via Sirt1-p53 pathway. Fundam Clin Pharmacol 28, 180-9
23384296 Curated Info |
|
Wu Y, et al. (2014) Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response. Mol Cell 53, 63-74
24289924 Curated Info |
|
Zhang ZN, Chung SK, Xu Z, Xu Y (2014) Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation. Stem Cells 32, 157-65
24038750 Curated Info |
|
Lau AW, Liu P, Inuzuka H, Gao D (2014) SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation. Am J Cancer Res 4, 245-55
24959379 Curated Info |
|
Shan X, et al. (2014) Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation. PLoS One 9, e115401
25521755 Curated Info |
|
Chang J, et al. (2013) Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress. EMBO J 32, 3192-205
24219989 Curated Info |
|
Zheng H, et al. (2013) hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1. Mol Cell Biol 33, 4960-70
24126058 Curated Info |
|
Wu J, et al. (2013) The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma. Dig Dis Sci 58, 3545-53
24077923 Curated Info |
|
Sen N, Kumari R, Singh MI, Das S (2013) HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress. Mol Cell 52, 406-20
24120667 Curated Info |
|
Kim SS, Benchimol S (2013) HDAC5--a critical player in the p53 acetylation network. Mol Cell 52, 289-90
24207022 Curated Info |
|
Yi G, et al. (2013) Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway. Int J Oncol 43, 1503-10
23982736 Curated Info |
|
Mellini P, et al. (2013) Screen of pseudopeptidic inhibitors of human sirtuins 1-3: two lead compounds with antiproliferative effects in cancer cells. J Med Chem 56, 6681-95
23927550 Curated Info |
|
Jin H, et al. (2013) HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells. J Cell Biochem 114, 1498-509
23297003 Curated Info |
|
Liu N, et al. (2013) ING5 Is a Tip60 Cofactor That Acetylates p53 in Response to DNA Damage. Cancer Res 73, 3749-60
23576563 Curated Info |
|
Brochier C, et al. (2013) Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci 33, 8621-32
23678107 Curated Info |
|
Armour SM, et al. (2013) A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex. Mol Cell Biol 33, 1487-502
23382074 Curated Info |
|
van Leeuwen IM, et al. (2013) Modulation of p53 C-Terminal Acetylation by mdm2, p14ARF, and Cytoplasmic SirT2. Mol Cancer Ther 12, 471-80
23416275 Curated Info |
|
Kim MK, et al. (2013) Regulation of the Cyclin-dependent Kinase Inhibitor 1A Gene (CDKN1A) by the Repressor BOZF1 through Inhibition of p53 Acetylation and Transcription Factor Sp1 Binding. J Biol Chem 288, 7053-64
23329847 Curated Info |
|
Rokudai S, et al. (2013) MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci U S A 110, 3895-900
23431171 Curated Info |
|
Xu S, et al. (2013) hSSB1 regulates both the stability and the transcriptional activity of p53. Cell Res 23, 423-35
23184057 Curated Info |
|
Thakur BK, et al. (2013) Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells. Int J Cancer 132, 766-74
22815158 Curated Info |
|
Chan C, et al. (2013) Altered Binding Site Selection of p53 Transcription Cassettes by Hepatitis B Virus X Protein. Mol Cell Biol 33, 485-97
23149944 Curated Info |
|
Wu D, et al. (2013) Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation. J Biol Chem 288, 1353-64
23148227 Curated Info |
|
Yang Y, et al. (2013) Polycomb Group Protein PHF1 Regulates p53-dependent Cell Growth Arrest and Apoptosis. J Biol Chem 288, 529-39
23150668 Curated Info |
|
Shahar OD, et al. (2013) acetylation of lysine 382 and phosphorylation of serine 392 in p53 modulate the interaction between p53 and MDC1 in vitro. PLoS One 8, e78472
24194938 Curated Info |
|
Bursać S, et al. (2012) Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc Natl Acad Sci U S A 109, 20467-72
23169665 Curated Info |
|
Liu L, et al. (2012) Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation. Hepatology 56, 1760-9
22576474 Curated Info |
|
Kim K, et al. (2012) Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription. Oncogene 31, 4290-301
22249259 Curated Info |
|
Piccinin S, et al. (2012) A "Twist box" Code of p53 Inactivation: Twist box:p53 Interaction Promotes p53 Degradation. Cancer Cell 22, 404-15
22975381 Curated Info |
|
Lee CW, et al. (2012) AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells. Cancer Res 72, 4394-404
22728651 Curated Info |
|
Mizuguchi Y, et al. (2012) SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity. BMC Mol Biol 13, 20
22731250 Curated Info |
|
Mahata B, Sundqvist A, Xirodimas DP (2012) Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner. Oncogene 31, 3060-71
22081073 Curated Info |
|
Kim WJ, Rivera MN, Coffman EJ, Haber DA (2012) The WTX tumor suppressor enhances p53 acetylation by CBP/p300. Mol Cell 45, 587-97
22285752 Curated Info |
|
Wang H, et al. (2012) The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage. DNA Repair (Amst) 11, 146-56
22112863 Curated Info |
|
Vigneron AM, Vousden KH (2012) An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence. EMBO J 31, 471-80
22068052 Curated Info |
|
Illuzzi JL, Vickers CA, Kmiec EB (2011) Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin. J Mol Neurosci 45, 256-68
21465263 Curated Info |
|
Xu S, et al. (2011) High-fat diet increases and the polyphenol, S17834, decreases acetylation of the sirtuin-1-dependent lysine-382 on p53 and apoptotic signaling in atherosclerotic lesion-prone aortic endothelium of normal mice. J Cardiovasc Pharmacol 58, 263-71
21654327 Curated Info |
|
Bug M, Dobbelstein M (2011) Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms. Oncogene 30, 3612-24
21441950 Curated Info |
|
Seo SK, et al. (2011) Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. J Thorac Oncol 6, 1313-9
21642861 Curated Info |
|
Debnath S, et al. (2011) Peptide-protein interactions suggest that acetylation of lysines 381 and 382 of p53 is important for positive coactivator 4-p53 interaction. J Biol Chem 286, 25076-87
21586571 Curated Info |
|
Audrito V, et al. (2011) Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res 71, 4473-83
21565980 Curated Info |
|
Kuroda T, et al. (2011) RNA content in the nucleolus alters p53 acetylation via MYBBP1A. EMBO J 30, 1054-66
21297583 Curated Info |
|
Savelyeva I, Dobbelstein M (2011) Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A. Oncogene 30, 865-75
20935676 Curated Info |
|
Mellert HS, et al. (2011) Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis. J Biol Chem 286, 4264-70
21148320 Curated Info |
|
Robers MB, et al. (2011) Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology. Mol Biosyst 7, 59-66
20931131 Curated Info |
|
Aranha MM, et al. (2011) miR-34a regulates mouse neural stem cell differentiation. PLoS One 6, e21396
21857907 Curated Info |
|
Kawano T, et al. (2010) Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation. Int J Oncol 37, 787-95
20811699 Curated Info |
|
Puca R, et al. (2010) Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radic Biol Med 48, 1338-46
20171273 Curated Info |
|
Guo X, Williams JG, Schug TT, Li X (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J Biol Chem 285, 13223-32
20167603 Curated Info |
|
Sinha S, et al. (2010) Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element. EMBO J 29, 830-42
20075864 Curated Info |
|
Eichenbaum KD, RodrÃguez Y, Mezei M, Osman R (2010) The energetics of the acetylation switch in p53-mediated transcriptional activation. Proteins 78, 447-56
19731376 Curated Info |
|
Nishimura T, et al. (2009) Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase. J Biol Chem 284, 36442-52
19861417 Curated Info |
|
van Dieck J, et al. (2009) Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53. J Mol Biol 394, 922-30
19819244 Curated Info |
|
Yadavilli S, Chen Z, Albrecht T, Muganda PM (2009) Mechanism of diepoxybutane-induced p53 regulation in human cells. J Biochem Mol Toxicol 23, 373-86
20024960 Curated Info |
|
Choudhary C, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-40
19608861 Curated Info |
|
Pavithra L, et al. (2009) SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription. J Mol Biol 388, 691-702
19303885 Curated Info |
|
Wu SY, Chiang CM (2009) Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. EMBO J 28, 1246-59
19339993 Curated Info |
|
Tian C, et al. (2009) KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol 11, 580-91
19377469 Curated Info |
|
Yamaguchi H, et al. (2009) p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions. J Biol Chem 284, 11171-83
19265193 Curated Info |
|
Allison SJ, Jiang M, Milner J (2009) Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging (Albany NY) 1, 316-27
20157519 Curated Info |
|
Itahana Y, Ke H, Zhang Y (2009) p53 Oligomerization is essential for its C-terminal lysine acetylation. J Biol Chem 284, 5158-64
19106109 Curated Info |
|
Zhu Z, et al. (2009) Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology 49, 504-12
19085961 Curated Info |
|
Kang H, Jung JW, Kim MK, Chung JH (2009) CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One 4, e6611
19680552 Curated Info |
|
Puca R, et al. (2009) HIPK2 modulates p53 activity towards pro-apoptotic transcription. Mol Cancer 8, 85
19828042 Curated Info |
|
Xenaki G, et al. (2008) PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene 27, 5785-96
18574470 Curated Info |
|
Warnock LJ, et al. (2008) Influence of tetramerisation on site-specific post-translational modifications of p53: comparison of human and murine p53 tumor suppressor protein. Cancer Biol Ther 7, 1481-9
18769132 Curated Info |
|
Chen JJ, Chou CW, Chang YF, Chen CC (2008) Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappaB and reactive oxygen species-mediated p53 activation. J Immunol 180, 8030-9
18523266 Curated Info |
|
Lin T, Mak NK, Yang MS (2008) MAPK regulate p53-dependent cell death induced by benzo[a]pyrene: Involvement of p53 phosphorylation and acetylation. Toxicology 247, 145-53
18406507 Curated Info |
|
Tang Y, et al. (2008) Acetylation is indispensable for p53 activation. Cell 133, 612-26
18485870 Curated Info |
|
Habold C, et al. (2008) Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. J Cell Mol Med 12, 607-21
18419600 Curated Info |
|
Warnock LJ, Adamson R, Lynch CJ, Milner J (2008) Crosstalk between site-specific modifications on p53 and histone H3. Oncogene 27, 1639-44
17891183 Curated Info |
|
Wang H, et al. (2008) An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of p53/p21Waf1/Cip1 in Response to 5-Aza-2'-deoxycytidine Treatment. J Biol Chem 283, 2564-74
17977830 Curated Info |
|
Kitagawa M, Lee SH, McCormick F (2008) Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell 29, 217-31
18243116 Curated Info |
|
Kim TK, et al. (2007) Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells. Cancer Res 67, 11133-40
18056437 Curated Info |
|
Li AG, et al. (2007) An acetylation switch in p53 mediates holo-TFIID recruitment. Mol Cell 28, 408-21
17996705 Curated Info |
|
Wong S, Weber JD (2007) Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1. Biochem J 407, 451-60
17620057 Curated Info |
|
Mantovani F, et al. (2007) The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol 14, 912-20
17906639 Curated Info |
|
Ivanov GS, et al. (2007) Methylation-acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol 27, 6756-69
17646389 Curated Info |
|
Shi X, et al. (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell 27, 636-46
17707234 Curated Info |
|
Giono LE, Manfredi JJ (2007) Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest. Mol Cell Biol 27, 4166-78
17371838 Curated Info |
|
Higashitsuji H, et al. (2007) Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. J Biol Chem 282, 13716-25
17353187 Curated Info |
|
Sasaki T, et al. (2007) HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev 21, 848-61
17403783 Curated Info |
|
Nag A, et al. (2007) An essential role of human Ada3 in p53 acetylation. J Biol Chem 282, 8812-20
17272277 Curated Info |
|
Stiehl DP, et al. (2007) Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. Cancer Res 67, 2256-64
17332356 Curated Info |
|
Roy S, Tenniswood M (2007) Site-specific acetylation of p53 directs selective transcription complex assembly. J Biol Chem 282, 4765-71
17121856 Curated Info |
|
Singh K, et al. (2007) p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion. PLoS One 2, e660
17668048 Curated Info |
|
Santillan DA, et al. (2006) Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype. Cancer Res 66, 10032-9
17047066 Curated Info |
|
Li AG, et al. (2006) Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 23, 575-87
16916644 Curated Info |
|
Enari M, Ohmori K, Kitabayashi I, Taya Y (2006) Requirement of clathrin heavy chain for p53-mediated transcription. Genes Dev 20, 1087-99
16618797 Curated Info |
|
Zhao Y, et al. (2006) Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol 26, 2782-90
16537920 Curated Info |
|
Gueven N, et al. (2006) Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype. Cancer Res 66, 2907-12
16540636 Curated Info |
|
Kobayashi T, et al. (2006) Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylation. Cancer Res 66, 3137-44
16540664 Curated Info |
|
Ho CC, et al. (2006) Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways. Cancer Res 66, 2233-41
16489026 Curated Info |
|
Kawaguchi Y, Ito A, Appella E, Yao TP (2006) Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 281, 1394-400
16291740 Curated Info |
|
Sachchidanand, et al. (2006) Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol 13, 81-90
16426974 Curated Info |
|
Herzer K, et al. (2005) Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res 65, 10830-7
16322229 Curated Info |
|
Wang C, et al. (2005) MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J 24, 3279-90
16107876 Curated Info |
|
Roy S, Packman K, Jeffrey R, Tenniswood M (2005) Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells. Cell Death Differ 12, 482-91
15746940 Curated Info |
|
Warnock LJ, Raines SA, Mee TR, Milner J (2005) Role of phosphorylation in p53 acetylation and PAb421 epitope recognition in baculoviral and mammalian expressed proteins. FEBS J 272, 1669-75
15794754 Curated Info |
|
Bandyopadhyay D, Mishra A, Medrano EE (2004) Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway. Cancer Res 64, 7706-10
15520174 Curated Info |
|
Vaghefi H, Neet KE (2004) Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. Oncogene 23, 8078-87
15361854 Curated Info |
|
Yeung F, et al. (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23, 2369-80
15152190 Curated Info |
|
Hsu CH, et al. (2004) HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J 23, 2269-80
15141169 Curated Info |
|
Stommel JM, Wahl GM (2004) Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO J 23, 1547-56
15029243 Curated Info |
|
Brunet A, et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-5
14976264 Curated Info |
|
Insinga A, et al. (2004) Impairment of p53 acetylation, stability and function by an oncogenic transcription factor. EMBO J 23, 1144-54
14976551 Curated Info |
|
Kaeser MD, Pebernard S, Iggo RD (2004) Regulation of p53 stability and function in HCT116 colon cancer cells. J Biol Chem 279, 7598-605
14665630 Curated Info |
|
Luo J, et al. (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A 101, 2259-64
14982997 Curated Info |
|
Mujtaba S, et al. (2004) Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell 13, 251-63
14759370 Curated Info |
|
Bronder JL, Moran RG (2003) A defect in the p53 response pathway induced by de novo purine synthesis inhibition. J Biol Chem 278, 48861-71
14517211 Curated Info |
|
Saito S, et al. (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 278, 37536-44
12860987 Curated Info |
|
Kataoka H, et al. (2003) ING1 represses transcription by direct DNA binding and through effects on p53. Cancer Res 63, 5785-92
14522900 Curated Info |
|
Zeng L, et al. (2003) The role of p53 deacetylation in p21Waf1 regulation by laminar flow. J Biol Chem 278, 24594-9
12716906 Curated Info |
|
Shiseki M, et al. (2003) p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 63, 2373-8
12750254 Curated Info |
|
Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277, 50607-11
12421820 Curated Info |
|
Ito A, et al. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21, 6236-45
12426395 Curated Info |
|
Takai H, et al. (2002) Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J 21, 5195-205
12356735 Curated Info |
|
Bischof O, et al. (2002) Deconstructing PML-induced premature senescence. EMBO J 21, 3358-69
12093737 Curated Info |
|
Langley E, et al. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21, 2383-96
12006491 Curated Info |
|
Saito S, et al. (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J Biol Chem 277, 12491-4
11875057 Curated Info |
|
Nakamura S, Roth JA, Mukhopadhyay T (2002) Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells. Oncogene 21, 2605-10
11971195 Curated Info |
|
Hofmann TG, et al. (2002) Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4, 1-10
11740489 Curated Info |
|
Kishi H, et al. (2001) Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20. J Biol Chem 276, 39115-22
11495913 Curated Info |
|
Vaziri H, et al. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-59
11672523 Curated Info |
|
Nagashima M, et al. (2001) DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci U S A 98, 9671-6
11481424 Curated Info |
|
Ito A, et al. (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20, 1331-40
11250899 Curated Info |
|
Nakamura S, Roth JA, Mukhopadhyay T (2000) Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol 20, 9391-8
11094089 Curated Info |
|
Luo J, et al. (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408, 377-81
11099047 Curated Info |
|
Pearson M, et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-10
10910364 Curated Info |
|
Xiao G, et al. (2000) A DNA damage signal is required for p53 to activate gadd45. Cancer Res 60, 1711-9
10749144 Curated Info |
|
Abraham J, Kelly J, Thibault P, Benchimol S (2000) Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry. J Mol Biol 295, 853-64
10656795 Curated Info |
|
Sakaguchi K, et al. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12, 2831-41
9744860 Curated Info |
|
Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606
9288740 Curated Info |